# Alzamend Neuro, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:5b6352c0-54b0-45af-8d6d-a6e478461035 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/alzamend-neuro-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 26 |
| Claims under review | 1 |
| Evidence records | 5 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-19T04:47:49.407702+00:00 |
| Last reviewed | 2026-10-19T04:47:49.407702+00:00 |

## Identity

- Legal name: Alzamend Neuro, Inc.
- Display name: Alzamend Neuro, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-19T04:47:49.407702+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.831 |
| Directors | 7 |
| Committees | 3 |
| Governance events | 8 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Henry Nisser: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-02-26. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:5
- Jeffrey Oram: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-02-26. Committees: Audit Committee (chair); compensation committee (chair); Nominating and Corporate Governance Committee (chair). claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:6
- Lynne F. McGrath: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-02-26. Committees: compensation committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:7
- Mark Gustafson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-02-26. Committees: Audit Committee (member); compensation committee (member). claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:8
- Milton C. Ault: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:9
- Stephan Jackman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-02-26. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:10
- WILLIAM B. HORNE: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. Committees: Audit Committee (member). claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:11

## Committees

- Audit Committee (audit). Chair: Jeffrey Oram. Members: Jeffrey Oram (chair, current); Mark Gustafson (member, current); WILLIAM B. HORNE (member, current). committee_id=alpha:committee:alzamend-neuro-inc:audit-committee
- compensation committee (compensation). Chair: Jeffrey Oram. Members: Jeffrey Oram (chair, current); Lynne F. McGrath (member, current); Mark Gustafson (member, current). committee_id=alpha:committee:alzamend-neuro-inc:compensation-committee
- Nominating and Corporate Governance Committee (nominating_governance). Chair: Jeffrey Oram. Members: Jeffrey Oram (chair, current); Lynne F. McGrath (member, current). committee_id=alpha:committee:alzamend-neuro-inc:nominating-and-corporate-governance-committee

## Executive leadership

- Kenneth S. Cragun: Senior Vice President of Finance. Status: current. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:14
- David J. Katzoff: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:12
- Henry Nisser: Executive Vice President and General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:13
- Stephan Jackman: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:15

## Governance events

- DIRECTOR_APPOINTED: Henry Nisser seat on Alzamend Neuro, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:146x2oe18t0x52
- DIRECTOR_APPOINTED: Jeffrey Oram seat on Alzamend Neuro, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:8lp3ln1elwc49
- DIRECTOR_APPOINTED: Lynne F. McGrath seat on Alzamend Neuro, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:ly5q5wmpwmqc
- DIRECTOR_APPOINTED: Mark Gustafson seat on Alzamend Neuro, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:tiusbx1lrkj2n
- DIRECTOR_APPOINTED: Stephan Jackman seat on Alzamend Neuro, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:11kv3w6o1kh96
- EXECUTIVE_APPOINTED: Kenneth S. Cragun executive of Alzamend Neuro, Inc., effective 2025-07-22. Effective: 2025-07-22. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:1klfbn4vkv57a
- DIRECTOR_APPOINTED: Milton C. Ault seat on Alzamend Neuro, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:1axbaio1r91nlu
- DIRECTOR_APPOINTED: WILLIAM B. HORNE seat on Alzamend Neuro, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-19T04:47:49.407702+00:00. event_id=alpha:event:transition:z9a4k61nsc8u6

## Scoped resources

- `alpha://company/alzamend-neuro-inc` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record
- `alpha://company/alzamend-neuro-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=identity
- `alpha://company/alzamend-neuro-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=corporate-structure
- `alpha://company/alzamend-neuro-inc/board` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=board
- `alpha://company/alzamend-neuro-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=committees
- `alpha://company/alzamend-neuro-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=leadership
- `alpha://company/alzamend-neuro-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=ownership
- `alpha://company/alzamend-neuro-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=financials
- `alpha://company/alzamend-neuro-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=capital-structure
- `alpha://company/alzamend-neuro-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=compensation
- `alpha://company/alzamend-neuro-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=governance
- `alpha://company/alzamend-neuro-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=shareholder-governance
- `alpha://company/alzamend-neuro-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=audit
- `alpha://company/alzamend-neuro-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=legal
- `alpha://company/alzamend-neuro-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=risk
- `alpha://company/alzamend-neuro-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=cyber
- `alpha://company/alzamend-neuro-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=ai-governance
- `alpha://company/alzamend-neuro-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=agents
- `alpha://company/alzamend-neuro-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=ecosystem
- `alpha://company/alzamend-neuro-inc/events` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=events
- `alpha://company/alzamend-neuro-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=relationships
- `alpha://company/alzamend-neuro-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=assessments
- `alpha://company/alzamend-neuro-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:jeffrey-oram","name":"Jeffrey Oram"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mark-gustafson","name":"Mark Gustafson"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:william-b-horne","name":"WILLIAM B. HORNE"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:21: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:jeffrey-oram","name":"Jeffrey Oram"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:22: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lynne-f-mcgrath-alzn","name":"Lynne F. McGrath"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:23: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mark-gustafson","name":"Mark Gustafson"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:jeffrey-oram","name":"Jeffrey Oram"},"source_id":"governance_people_committees"}`
- Claim alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lynne-f-mcgrath-alzn","name":"Lynne F. McGrath"},"source_id":"governance_people_committees"}`

## Leadership

- Henry Nisser: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:5. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- Jeffrey Oram: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:6. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- Lynne F. McGrath: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:7. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- Mark Gustafson: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:8. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- Milton C. Ault: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:9. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- Stephan Jackman: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:10. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- WILLIAM B. HORNE: Director. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:11. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11.
- David J. Katzoff: Chief Financial Officer. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:770c4cd29203b9aa3f0c77da6c867881b9e889aabe9fb780037f11ee8b4db4a3.
- Henry Nisser: Executive Vice President and General Counsel. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:770c4cd29203b9aa3f0c77da6c867881b9e889aabe9fb780037f11ee8b4db4a3.
- Kenneth S. Cragun: Senior Vice President of Finance. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:14. Valid from: 2025-07-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7130df33c082dbe2817909e9e4a57ceef1bedc922a125b8322a7762c574a37d0.
- Stephan Jackman: Chief Executive Officer. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:770c4cd29203b9aa3f0c77da6c867881b9e889aabe9fb780037f11ee8b4db4a3.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit Committee: Chair Jeffrey Oram; Members Jeffrey Oram (Chair); Mark Gustafson; WILLIAM B. HORNE. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- compensation committee: Chair Jeffrey Oram; Members Jeffrey Oram (Chair); Lynne F. McGrath; Mark Gustafson. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Nominating and Corporate Governance Committee: Chair Jeffrey Oram; Members Jeffrey Oram (Chair); Lynne F. McGrath. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Alzamend Neuro, Inc.. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73f44362abc446b13e5046089031b6c8b600c1a1c2b37a7e137a996739750aa.

## Entity Status

- Public listing published. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73f44362abc446b13e5046089031b6c8b600c1a1c2b37a7e137a996739750aa.

## Published Fact

- US. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73f44362abc446b13e5046089031b6c8b600c1a1c2b37a7e137a996739750aa.

## Committee Appointment

- Jeffrey Oram: chair, Audit Committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Mark Gustafson: member, Audit Committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- WILLIAM B. HORNE: member, Audit Committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Jeffrey Oram: chair, compensation committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Lynne F. McGrath: member, compensation committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Mark Gustafson: member, compensation committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Jeffrey Oram: chair, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.
- Lynne F. McGrath: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b.

## Security Listing

- ALZN (NASDAQ). Claim: alpha:claim:company:5b6352c0-54b0-45af-8d6d-a6e478461035:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c73f44362abc446b13e5046089031b6c8b600c1a1c2b37a7e137a996739750aa.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:c73f44362abc446b13e5046089031b6c8b600c1a1c2b37a7e137a996739750aa: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/alzamend-neuro-inc).
- alpha:projection-evidence:document:1164e614ff56fceb4da01182f22adf661dc6165a6245d8ea7093dbc3eab08c11: [DEF 14A i225262def14a.htm](https://www.sec.gov/Archives/edgar/data/1677077/000121465926002583/i225262def14a.htm).
- alpha:projection-evidence:document:770c4cd29203b9aa3f0c77da6c867881b9e889aabe9fb780037f11ee8b4db4a3: [SEC DEF 14A 0001214659-26-002583](https://www.sec.gov/Archives/edgar/data/1677077/000121465926002583/i225262def14a.htm).
- alpha:projection-evidence:document:7130df33c082dbe2817909e9e4a57ceef1bedc922a125b8322a7762c574a37d0: [ALZN 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1677077/000121465925010763/u7925110k.htm).
- alpha:projection-evidence:e68bff36e3675000ae4a1f359257168afb7421bca2f3478a8d643638f806cc4b: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1677077/000121465926002583/i225262def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/alzamend-neuro-inc)
- [Public Markdown](https://registry.alpha.ac/companies/alzamend-neuro-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/alzamend-neuro-inc?format=jsonld)
- MCP resource: `alpha://companies/alzamend-neuro-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-10-19T13:44:47.443609+00:00; recorded 2026-10-19T13:44:47.443609+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.